BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 37175443)

  • 1. Autophagy and SARS-CoV-2-Old Players in New Games.
    Ivanova T; Mariienko Y; Mehterov N; Kazakova M; Sbirkov Y; Todorova K; Hayrabedyan S; Sarafian V
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional interplay between SARS-CoV-2 and autophagy.
    Zhou H; Hu Z; Castro-Gonzalez S
    mBio; 2023 Aug; 14(4):e0102023. PubMed ID: 37436071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.
    Bello-Perez M; Sola I; Novoa B; Klionsky DJ; Falco A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32635598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade.
    Cloherty APM; Rader AG; Patel KS; Pérez-Vargas J; Thompson CAH; Ennis S; Niikura M; Wildenberg ME; Muncan V; Schreurs RRCE; Jean F; Ribeiro CMS
    Emerg Microbes Infect; 2023 Dec; 12(1):2195020. PubMed ID: 36951188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19.
    He W; Gao Y; Zhou J; Shi Y; Xia D; Shen HM
    Int J Biol Sci; 2022; 18(12):4690-4703. PubMed ID: 35874956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.
    Siri M; Dastghaib S; Zamani M; Rahmani-Kukia N; Geraylow KR; Fakher S; Keshvarzi F; Mehrbod P; Ahmadi M; Mokarram P; Coombs KM; Ghavami S
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Harnesses Host Translational Shutoff and Autophagy To Optimize Virus Yields: the Role of the Envelope (E) Protein.
    Waisner H; Grieshaber B; Saud R; Henke W; Stephens EB; Kalamvoki M
    Microbiol Spectr; 2023 Feb; 11(1):e0370722. PubMed ID: 36622177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role and clinical implication of autophagy in COVID-19.
    Shan T; Li LY; Yang JM; Cheng Y
    Virol J; 2023 Jun; 20(1):125. PubMed ID: 37328875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 ORF3a inhibits cGAS-STING-mediated autophagy flux and antiviral function.
    Su J; Shen S; Hu Y; Chen S; Cheng L; Cai Y; Wei W; Wang Y; Rui Y; Yu XF
    J Med Virol; 2023 Jan; 95(1):e28175. PubMed ID: 36163413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition.
    Bestion E; Zandi K; Belouzard S; Andreani J; Lepidi H; Novello M; Rouquairol C; Baudoin JP; Rachid M; La Scola B; Mege JL; Dubuisson J; Schinazi RF; Mezouar S; Halfon P
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy in Inflammatory Response against SARS-CoV-2.
    Resnik R; Lopez Mingorance F; Rivera F; Mitchell F; Gonzalez CD; Vaccaro MI
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19.
    Yang N; Shen HM
    Int J Biol Sci; 2020; 16(10):1724-1731. PubMed ID: 32226290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein.
    Vankadari N
    Int J Antimicrob Agents; 2020 Aug; 56(2):105998. PubMed ID: 32360231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation.
    Shilagardi K; Spear ED; Abraham R; Griffin DE; Michaelis S
    mBio; 2022 Oct; 13(5):e0254322. PubMed ID: 36197088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches.
    Ahmadi S; Bazargan M; Elahi R; Esmaeilzadeh A
    Mol Immunol; 2023 Apr; 156():10-19. PubMed ID: 36857806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management.
    Bala A; Sengupta A; Matsabisa MG; Chabalala HP
    Curr Mol Pharmacol; 2021 Oct; 14(4):509-519. PubMed ID: 32867666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data.
    Rommasi F; Nasiri MJ; Mirsaiedi M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4163-4173. PubMed ID: 34156698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.